SN
Sadeghian, Nastaran
22 yayın · 426 atıf · 2021–2026
Yayın
22
Atıf
426
Yıllar
6
Yayınlar
| Başlık | Yıl | Tip | Atıf |
|---|---|---|---|
|
Synthesis, single-crystal X-Ray, molecular docking studies, and metabolic enzyme inhibition properties of novel Co(II) metal complex
|
2026 | Article | 0 |
|
Development of novel Phthalocyanine/Graphene oxide Composite: Potential usage for Sono/Photochemical Applications, and the treatment of type-2 diabetes and Alzheimer's disease
|
2025 | Article | 9 |
|
Design of novel benzimidazole-propane hydrazide derivatives as α-glucosidase and α-amylase inhibitors: in vitro and in silico studies
|
2025 | Article | 7 |
|
Synthesis and biological studies of acetophenone-based novel chalcone, semicarbazone, thiosemicarbazone and indolone derivatives: Structure-Activity relationship, molecular docking, molecular dynamics, and kinetic studies
|
2025 | Article | 27 |
|
Novel diazen-bis(phenoxy-1,2,3-triazole-N-phenylacetamide) derivatives as potent anti-cholinesterase, anti-α-glycosidase and anti-a-amylase agents: <i>In vitro</i> and <i>in silico</i> evaluations
|
2025 | Article | 1 |
|
Water-soluble metallophthalocyanines bearing 1-naphthoxy-4-sulfonic acid sodium salts: Sono-Photochemical and enzyme inhibition potential with molecular docking analysis
|
2025 | Article | 1 |
|
4-Phenylthiazol-1,2,3-triazole derivatives as new potential α-glucosidase and α-amylase inhibitors
|
2025 | Article | 8 |
|
Novel hydrazones derived from anthranilic acid as potent cholinesterases and α-glycosidase inhibitors: Synthesis, characterization, and biological effects
|
2024 | Article | 26 |
|
Novel composite structures based on cobalt phthalocyanine/graphene oxide: Identification of potential drug candidates to treat Alzheimer's disease and diabetes
|
2024 | Article | 18 |
|
Novel regioselective sulfamidomethylation of phenols: Synthesis characterization, biological effects, and molecular docking study
|
2024 | Article | 2 |
|
Synthesis of pyrrole-heterocyclic derivatives as anti-Alzheimer and antidiabetic candidates: An in vitro-in silico study
|
2024 | Article | 39 |
|
Synthesis, characterization, crystal structure, molecular docking, and biological studies of Cu, Ni and Co metal complexes of pyrazole
|
2024 | Article | 9 |
|
New Azo Derivative of β-Diketones and Its Cu(II), Co(II) Complexes: Synthesis, Theoretical Study and Biological Activity
|
2024 | Article | 4 |
|
Functionally substituted derivatives of novel thiourea and phenylthiourea as potent aldose reductase, α-amylase, and α-glycosidase inhibitors: in vitro and in silico studies
|
2024 | Article | 5 |
|
Novel Quinazolinone Derivatives: Potential Synthetic Analogs for the Treatment of Glaucoma, Alzheimer's Disease and Diabetes Mellitus
|
2023 | Article | 40 |
|
Synthesis of new carboxylates and sulfonates containing thiazolidin-4-one ring and evaluation of inhibitory properties against some metabolic enzymes
|
2023 | Article | 38 |
|
Design, Synthesis, Characterization and Biological Activities of Novel S-(Acyloxy)butyl-N,N-Diethyldithiocarbamate Compounds
|
2023 | Article | 10 |
|
Synthesis, Characterization, Bioactivity Impacts of New Anthranilic Acid Hydrazones Containing Aryl Sulfonate Moiety as Fenamate Isosteres
|
2023 | Article | 33 |
|
Biological Activity and Molecular Docking Study of Some Bicyclic Structures: Antidiabetic and Anticholinergic Potentials
|
2022 | Article | 21 |
|
Novel quinazolin-sulfonamid derivatives: synthesis, characterization, biological evaluation, and molecular docking studies
|
2022 | Article | 15 |
|
Probing 4-(diethylamino)-salicylaldehyde-based thiosemicarbazones as multi-target directed ligands against cholinesterases, carbonic anhydrases and α-glycosidase enzymes
|
2021 | Article | 80 |
|
The biological activities, molecular docking studies, and anticancer effects of 1-arylsuphonylpyrazole derivatives
|
2021 | Article | 33 |